Evogene Market Cap

Evogene has a market cap or net worth of 33.87 million as of February 21, 2025. Its market cap has decreased by -75.73% in one year.

Market Cap

33.87M

Enterprise Value

23.88M

Revenue

27.80M

Ranking

n/a

PE Ratio

n/a

Stock Price

522.60

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 33.87M, a decrease of -70.07%. That is a compound annual growth rate of -6.71%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	33.87M	-28.48%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	69.16B
Danel (Adir Yeoshua)	2.53B
Kamada	1.57B
Bait Bakfar	1.09B
Novolog (Pharm-Up 1966)	907.03M
Ilex Medical	800.59M
BrainsWay	762.81M
SofWave Medical	597.96M

Market Cap Rankings